Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging.,Nature Reviews Cardiology

当前位置： X-MOL 学术 › Nat. Rev. Cardiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging.
Nature Reviews Cardiology ( IF 41.7 ) Pub Date : 2019-12-09 , DOI: 10.1038/s41569-019-0305-z
Pankaj Garg ₁ , Andrew J Swift ₁ , Liang Zhong ₂ , Carl-Johan Carlhäll ₃ , Tino Ebbers ₃ , Jos Westenberg ₄ , Michael D Hope ₅ , Chiara Bucciarelli-Ducci ₆ , Jeroen J Bax ₇ , Saul G Myerson ₈

Affiliation

Mitral regurgitation (MR) is a common valvular heart disease and is the second most frequent indication for heart valve surgery in Western countries. Echocardiography is the recommended first-line test for the assessment of valvular heart disease, but cardiovascular magnetic resonance imaging (CMR) provides complementary information, especially for assessing MR severity and to plan the timing of intervention. As new CMR techniques for the assessment of MR have arisen, standardizing CMR protocols for research and clinical studies has become important in order to optimize diagnostic utility and support the wider use of CMR for the clinical assessment of MR. In this Consensus Statement, we provide a detailed description of the current evidence on the use of CMR for MR assessment, highlight its current clinical utility, and recommend a standardized CMR protocol and report for MR assessment.

中文翻译：

通过心血管磁共振成像评估二尖瓣关闭不全。

二尖瓣反流（MR）是一种常见的瓣膜性心脏病，是西方国家心脏瓣膜手术的第二常见适应症。超声心动图是评估瓣膜性心脏病的推荐一线检查，但心血管磁共振成像 (CMR) 提供了补充信息，特别是用于评估 MR 严重程度和计划干预时机。随着用于评估 MR 的新 CMR 技术的出现，标准化用于研究和临床研究的 CMR 协议已变得重要，以优化诊断效用并支持更广泛地使用 CMR 进行 MR 临床评估。在本共识声明中，我们详细描述了使用 CMR 进行 MR 评估的当前证据，强调其当前的临床效用，

更新日期：2019-12-09

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11